|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/00 | |
| A61K 38/29 | |||
| A61P 19/08 | |||
| A61P 19/10 | |||
| A61K 38/22 | |||
| A61K 38/27 | |||
| A61K 38/17 |
| (11) | Patento numeris | 2914277 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13851864.2 |
| Europos patento paraiškos padavimo data | 2013-11-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-09-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/068009 |
| Data | 2013-11-01 |
| (87) | Numeris | WO 2014/071158 |
| Data | 2014-05-08 |
| (30) | Numeris | Data | Šalis |
| 201261721898 P | 2012-11-02 | US | |
| 201261740665 P | 2012-12-21 | US |
| (72) |
SLOAN, Victor, Schorr, US
HRUSKA, Keith, US
FANG, Yifu, US
SUNG, Victoria, US
STEVENS, Randall, US
SMITH, William, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
Washington University, One Brookings Drive, Saint Louis, MO 63130, US Sloan, Victor Schorr, 34 Stirrup Lane, Flemington, NJ 08822, US Hruska, Keith, One Brookings Drive, St. Louis, MO 63130, US Fang, Yifu, One Brookings Drive, St. Louis, MO 63130, US |
| (54) | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DISORDERS |
| ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DISORDERS |